Xtx Topco LTD Vir Biotechnology, Inc. Transaction History

Xtx Topco LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$7.63 - $12.66 $369,284 - $612,731	48,399 New	48,399 $430,000
Q3 2023 Nov 13, 2023	BUY	$9.14 - $24.62 $404,033 - $1.09 Million	44,205 New	44,205 $414,000
Q4 2022 Feb 14, 2023	SELL	$19.96 - $28.22 $67,025 - $94,762	-3,358 Reduced 29.32%	8,096 $204,000
Q3 2022 Nov 14, 2022	BUY	$18.26 - $31.1 $209,150 - $356,219	11,454 New	11,454 $221,000

218

87M

127K

1.19M

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $982M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.